FAFarzaneh Barkhordari Ahmadi

Farzaneh Barkhordari Ahmadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Farzaneh Barkhordari Ahmadi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effect of body mass index on estimated glomerular filtration rate in patients with IgA nephropathy; a systematic review and meta-analysis of the cohort studies

    by Hossein Mardanparvar, Hediyeh Mesbahi, Sara Rasta, Rasoul Jafari Arismani, Sara Ghaseminejad Kermani, Leila Jampour, Alireza Amanollahi, Farzaneh Barkhordari Ahmadi, Nahid Moradi, Mahin Roozitalab

    Introduction: The study is motivated by the growing concern surrounding chronic kidney disease worldwide and the need for early identification and effective management to slow or prevent kidney disease progression. To achieve this goal, we evaluated the correlation between body mass index (BMI) and estimated glomerular filtration rate (eGFR) in patients with IgA nephropathy through a systematic review and meta-analysis. Materials and Methods: The data were acquired after conducting a comprehensive exploration of the international databases of PubMed, Scopus, Web of Science, Cochrane, and the Google Scholar search engine until June 2024. The study heterogeneity was evaluated utilizing the I2 index. The data were scrutinized employing STATA 14, and a P value < 0.05 was considered significant. Results: Seven studies with a sample size of 1354 normal BMI people and 1020 obese or overweight patients were included in this meta-analysis. Based on the findings of the weighted mean difference (WMD), individuals who are overweight or obese had a lower eGFR (WMD = -7.34 [CI; -9.62, -5.05], P<0.001). Conclusion: The results demonstrated that the eGFR was significantly lower in obese or overweight people compared to individuals with normal BMI; therefore, we conclude that being overweight or obese may hurt kidney function. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (CRD42023417633) and Research Registry (UIN: reviewregistry1665) websites.

  • Open Access

    Prevalence and causes of gynecological surgery cancellations at Shariati Bandar Abbas hospital

    by Banafsheh Tehranineshat, Nasim Zaman Samghabadi, Zahra Shahryarpanah, Zahra Eydizadeh, Roya Raeisi Jaski, Zahra Ziaadini, Farzaneh Barkhordari Ahmadi, Majid Vatankhah, Jahanbakhsh Vahdatnejad, Hossein Mardanparvar, et al.

    Introduction: Surgery cancellation causes complications such as disrupting the daily schedule of surgery in the operating room, delays in patient care, and potential financial losses for the hospital or surgical center. Objectives: This study aimed to investigate the prevalence and causes of gynecological surgery cancellations at Shariati Bandar Abbas hospital. Patients and Methods: This descriptive-analytical study was conducted on 212 patients in the Shariati hospital of Bandar Abbas, Iran, from April to November 2023. Data were collected through a demographic questionnaire and a researcher-made checklist, including clinical data. To analyze data SPSS version 27 and analytical tests were used. Results: Out of 212 studied patients, the surgery for 67 was canceled, resulting in a surgery canceling prevalence rate of 31.6%. Surgery type, age, history of diabetes mellitus, thyroid disease, and other diseases were not risk factors for surgery cancelation (P>0.05); however, cardiovascular disease history, not being nil per os (NPO), and not having surgery consent were independent risk factors (P<0.05). Conclusion: In conclusion, the high prevalence of surgery cancellations in Iran’s educational hospitals necessitates a comprehensive and systematic investigation of the factors involved, including patient evaluation, anesthesiologist approval, patient readiness, and the impact on patients’ overall health and well-being.

  • Open Access

    Onconephropathology; an emerging field of medicine

    by Anna Ghorbani, Marzieh Soltanian, Farzaneh Barkhordari Ahmadi, Mahsa Asadollahi Hamedani, Mahboubeh Belali Kharaji, Najmeh Parsai, Amirhossein Khoshghadam

    Onconephropathology; an emerging field of medicine

  • Open Access

    The effect of allopurinol on serum uric acid levels in patients with diabetic nephropathy; a systematic review and meta-analysis on randomized clinical trials

    by Jafar Kolahi, Soleyman Alivand, Noorbakhsh Alivand, Sara Dehghan, Farzaneh Barkhordari Ahmadi, Najmeh Parsai, Mohammad Hossein Taklif, Reyhaneh Sadeghian, Hossein Mardanparvar

    Introduction: The correlation between hyperuricemia and chronic kidney disease (CKD) is an approval issue; this study aimed to evaluate the effect of allopurinol on serum uric acid levels in patients with diabetic nephropathy, with the review of randomized clinical trials (RCTs). Materials and Methods: This meta-analysis study was conducted on RCTs in diabetic nephropathy patients, which evaluated the effect of allopurinol on serum uric acid levels. Data were collected by searching international databases and Google Scholar search engines until May 2023. STATA 14 software and the random effects model were conducted to analyze the data. A P value less than 0.05 was considered significant. Results: In this study, five studies with a sample size of 942 patients were assessed. The effect of allopurinol on serum uric acid in comparison to the placebo group deduced that the standard mean difference between the allopurinol group and placebo group was -1.55 mg/dL, which was statistically significant (CI: -2.07 to -1.02). Conclusion: Allopurinol through its uric acid lowering effect would be beneficial for patients with diabetic nephropathy in preventing the progression of CKD. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO website (ID: CRD42023412051).